AYURVEDIC MANAGEMENT OF RAYNAUD’S SYNDROME SECONDARY TO INFLAMMATORY POLY ARTHRITIS VIA UTTANA VATARAKTA AND SANDHI-SIRAGATA VATA FRAMEWORKS: A CASE REPORT
DOI:
https://doi.org/10.70057/ijaar.2026.70906Keywords:
Raynaud’s phenomenon;, inflammatory polyarthritis;, Uttana Vatarakta;, Sandhi Gata Vata;, Sira Gata Vata;, Antaparimarjjana Chikitsa;, Bahiparimarjjana Chikitsa.Abstract
Raynaud's phenomenon (RP) is an episodic, vasospastic disorder typically characterized by digital vascular compromise following exposure to cold and/or emotional stressors, commonly associated with underlying autoimmune and inflammatory conditions. Its clinical presentation may significantly affect quality of life, particularly when associated with inflammatory polyarthritis. This case report details the successful remote Ayurvedic management of Raynaud’s phenomenon secondary to inflammatory polyarthritis in a female patient presenting with cold-induced digital color changes, severe paresthesia, and joint pain. Clinical manifestations were correlated with Uttana Vatarakta and Sandhi-Siragata Vata. Intervention combined Antaparimarjjana Chikitsa (internal formulations such as Rasna Saptakam Kwatha, Punarnnavadi Kwatham, Yogaraja Guggulu, Chandraprabha Vatika, etc.), Bahiaparimarjjana Chikitsa (external therapies such as Local lepa(paste application), abhyanga(oil massage), parisheka (affusion), sirodhara (pouring oil over the head in a continuous stream), etc.), and sodhana chikitsa (purificatory treatments): Virechana (purgation). Treatments significantly reduced vasospastic attack frequency and severity, resolved numbness, and relieved polyarticular pain and morning stiffness. This study demonstrates a non-invasive, structured Ayurvedic protocol for secondary Raynaud's phenomenon that can be delivered via telemedicine, offering a practical integrative alternative when standard vasodilators or immunosuppressants are insufficient or poorly tolerated.
Downloads
Published
How to Cite
Issue
Section
Copyright (c) 2026 Sheena Sooraj

This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
